![](/img/cover-not-exists.png)
1413TiP LIBRETTO-431: Selpercatinib in treatment (Tx)-naïve patients with RET fusion-positive (RET+) non-small cell lung cancer (NSCLC)
Loong, H.H.F., Goto, K., Elamin, Y.Y., Solomon, B., Santini, F.C., Soldatenkova, V., Sashegyi, A., Lin, A. Bence, Lin, B.K., Wolf, J., Oxnard, G.R., Zhou, C., Drilon, A., Park, K.Volume:
31
Journal:
Annals of Oncology
DOI:
10.1016/j.annonc.2020.08.1727
Date:
September, 2020
File:
PDF, 69 KB
2020